TG Therapeutics, Inc. (TGTX)
TGTX price $53.23 -1.30 -2.38%
- Ticker
- TGTX
- Price
- $53.23
- Change
- -1.30 -2.38%
- Market cap
- $8.15B
- P/E
- 17.91
- Forward P/E
- 53.26
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 50
Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions. The company's focus areas specifically include B-cell related cancers (malignancies) and various autoimmune disorders. Among its significant investigational…